VITRICINE

This brand name is authorized in Nigeria.

Active ingredients

The drug VITRICINE contains one active pharmaceutical ingredient (API):

1	Tetryzoline UNII 0YZT43HS7D - TETRAHYDROZOLINE HYDROCHLORIDE
	Tetryzoline is an alpha adrenergic receptor agonist, which is used in form of nasal solution or spray for decongestion of nasal and nasopharyngeal mucosa.
	Read more about Tetryzoline

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
04-4112	Eye drops	VITRICINE EYE DROP SOL_DROPS 0.05% X 15ML	RNW-PP-311175 VITRICINE EYE DROP TETRAHYDROZOLINE HYDROCHLORIDE Tetrahydrozoline hydrochloride 0.30kg, Sodium chloride 1.35kg, Sodium borate 0.31kg, Boric acid 7.40kg, Disodium edetate 0.60kg, Benzalkonium chloride 95% 0.07, Water for injection to 600.00L Apr-12 Drugs Nigerian Products X15ml POM 1 2/1/2023 DRUGFIELD PHARMACEUTICALS LIMITED., LYNSON CHEMICAL AVENUE, KM 38 LAGOS-ABEOKUTA EXPRESSWAY, SANGO-OTA,OGUN STATE 8029055002 info@drugfieldpharma.com DRUGFIELD PHARMACEUTICALS LIMITED, 48, AKEJU STREET, PALMGROVE, SOMOLU, LAGOS STATE. P.O BOX 5831, IKEJA, LAGOS STATE., Nigeria	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01GA02	Tetryzoline	S Sensory organs → S01 Ophthalmologicals → S01G Decongestants and antiallergics → S01GA Sympathomimetics used as decongestants
Discover more medicines within S01GA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	04-4112